Duloxetine vs placebo in the prevention of relapse of major depressive disorder

被引：4
|
作者：
Detke, M
Gilaberte, I
Perahia, D
Wang, F
McNamara, R
Tran, P
Miner, C
Montgomery, SA
机构：
[1] Eli Lilly & Co, Duloxetine Fluoxetine Product team, Indianapolis, IN 46285 USA
[2] Imperial Coll Sci Technol & Med, London, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91914-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S261 / S262
页数：2
相关论文
共 50 条
  • [1] Duloxetine vs placebo in the prevention of relapse of Major Depressive Disorder
    Detke, MJ
    Gilaberte, I
    Perahia, DG
    Clemens, JW
    Tran, PV
    Miner, C
    Montgomery, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S175 - S175
  • [2] Duloxetine vs. placebo in the prevention of relapse of major depressive disorder
    Detke, MJ
    Gilaberte, I
    Perahia, DG
    Wang, F
    Lee, TC
    Tran, PV
    Miner, CM
    Montgomery, SA
    [J]. EUROPEAN PSYCHIATRY, 2004, 19 : 214S - 214S
  • [3] Duloxetine in the prevention of relapse of major depressive disorder - Double-blind placebo-controlled study
    Perahia, DG
    Gilaberte, I
    Wang, FJ
    Wiltse, CG
    Huckins, SA
    Clemens, JW
    Montgomery, SA
    Montejo, AL
    Detke, MJ
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 346 - 353
  • [4] Relapse prevention in major depressive disorder: Pharmacotherapy vs continuation ECT
    Husain, MM
    Guzman, R
    Oberg, M
    Claxton, A
    Rush, AJ
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1996, 4 (04): : 364 - 364
  • [5] Desvenlafaxine succinate versus Placebo for prevention of depressive relapse in adult outpatients with major depressive disorder
    Pitrosky, B.
    Rickels, K.
    Montgomery, S.
    Tourian, K.
    Guelfi, J. D.
    Padmanabhan, S. K.
    Germain, J. M.
    Leurent, C.
    Brisard, C.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 335 - 336
  • [6] Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder
    Fava, Maurizio
    Wiltse, Curtis
    Walker, Daniel
    Brecht, Stephan
    Chen, Andrew
    Perahia, David
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 113 (03) : 263 - 271
  • [7] The safety and tolerability of duloxetine vs. placebo in the treatment of elderly patients with major depressive disorder (MDD)
    Raskin, J
    Wiltse, C
    Dinkel, J
    Xu, J
    Katona, C
    Gandhi, P
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A47 - A47
  • [8] Efficacy of duloxetine vs. placebo in mild, moderate, and more severely ill patients with major depressive disorder
    Prakash, A.
    Pons, A.
    Shelton, R.
    Mallinckrodt, C.
    Robinson, M.
    Wohlreich, M.
    Raskin, J.
    Detke, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S246 - S246
  • [9] Duloxetine Fights Major Depressive Disorder
    Wimett, Lynn
    Laustsen, Gary
    [J]. NURSE PRACTITIONER, 2005, 30 (03): : 6 - 7
  • [10] MIRTAZAPINE VS AMITRIPTYLINE VS PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
    SMITH, WT
    GLAUDIN, V
    PANAGIDES, J
    GILVARY, E
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1990, 26 (02) : 191 - 196
12345